eli lilly tirzepatide news today launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Lilly CEO says weight-loss drug

For comprehensive care that's faster, smarter, and more personal, skip the line and talk to an AI Doctor now, for free

Questions to ask your doctor about tirzepatide for weight loss Here are some questions you may want to ask your healthcare provider when you meet with them to discuss taking tirzepatide for weight loss

Retatrutide represents a newer option that adds glucagon receptor agonism to GLP-1 and GIP activation, creating a triple agonist

Adverse events outcomes (n = 21,229) were reported including 1,039 deaths (4.9% of all reports), 1,613 life-threatening events (7.6%), and 7,426 hospitalizations (35%)

Check that the gray plunger is visible

However, we recommend following a balanced, nutritious diet to maximize the benefits of the medication and support overall health